ATE482920T1 - Halogenphenylderivatzwischen produkte und deren verwendung in einem verfahren zur herstellung von azolderivaten - Google Patents

Halogenphenylderivatzwischen produkte und deren verwendung in einem verfahren zur herstellung von azolderivaten

Info

Publication number
ATE482920T1
ATE482920T1 AT02754691T AT02754691T ATE482920T1 AT E482920 T1 ATE482920 T1 AT E482920T1 AT 02754691 T AT02754691 T AT 02754691T AT 02754691 T AT02754691 T AT 02754691T AT E482920 T1 ATE482920 T1 AT E482920T1
Authority
AT
Austria
Prior art keywords
sup
derivatives
halophenyl
intermediate products
halogen
Prior art date
Application number
AT02754691T
Other languages
German (de)
English (en)
Inventor
Milan Soukup
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of ATE482920T1 publication Critical patent/ATE482920T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/483Monocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT02754691T 2001-06-26 2002-06-17 Halogenphenylderivatzwischen produkte und deren verwendung in einem verfahren zur herstellung von azolderivaten ATE482920T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01115355 2001-06-26
PCT/EP2002/006644 WO2003002498A1 (en) 2001-06-26 2002-06-17 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives

Publications (1)

Publication Number Publication Date
ATE482920T1 true ATE482920T1 (de) 2010-10-15

Family

ID=8177821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02754691T ATE482920T1 (de) 2001-06-26 2002-06-17 Halogenphenylderivatzwischen produkte und deren verwendung in einem verfahren zur herstellung von azolderivaten

Country Status (17)

Country Link
US (1) US7115643B2 (enExample)
EP (1) EP1399402B1 (enExample)
JP (1) JP4125672B2 (enExample)
KR (1) KR100898887B1 (enExample)
CN (1) CN1223564C (enExample)
AT (1) ATE482920T1 (enExample)
AU (1) AU2002321068B2 (enExample)
BR (1) BR0210701A (enExample)
CA (1) CA2449800C (enExample)
CY (1) CY1111510T1 (enExample)
DE (1) DE60237817D1 (enExample)
DK (1) DK1399402T3 (enExample)
ES (1) ES2349918T3 (enExample)
MX (1) MXPA03010914A (enExample)
PT (1) PT1399402E (enExample)
WO (1) WO2003002498A1 (enExample)
ZA (1) ZA200309101B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207352B2 (en) * 2009-10-08 2012-06-26 Drug Process Licensing Associates LLC Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
HUE031679T2 (en) 2012-08-07 2017-07-28 Basilea Pharmaceutica Ag Process for the preparation of isavuconazole or ravuconazole
US20140371179A1 (en) * 2013-06-13 2014-12-18 Professional Compounding Centers Of America Methods and Compositions for Treating Esophageal Diseases
CN105801500B (zh) * 2014-12-31 2018-08-24 四川科伦药物研究院有限公司 拆分艾沙康唑中间化合物消旋体的方法
CN115611822B (zh) * 2022-10-12 2023-09-19 四川澄华生物科技有限公司 艾沙康唑中间体的制备方法
CN116478103B (zh) * 2023-03-24 2025-07-25 四川澄华生物科技有限公司 一种拆分艾沙康唑中间体4的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395942A (en) * 1980-06-02 1995-03-07 Zeneca Limited Heterocyclic compounds
DE3942790A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur herstellung von 2-(4-chlorphenyl)-3-methylbuttersaeure
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
JP3471831B2 (ja) * 1991-12-09 2003-12-02 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩
ES2062941B1 (es) * 1993-03-15 1995-10-01 Uriach & Cia Sa J Nuevos derivados de azol activos por via oral.
NZ270418A (en) 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions

Also Published As

Publication number Publication date
CN1223564C (zh) 2005-10-19
US7115643B2 (en) 2006-10-03
DK1399402T3 (da) 2010-11-15
KR20040012982A (ko) 2004-02-11
PT1399402E (pt) 2010-11-30
EP1399402A1 (en) 2004-03-24
DE60237817D1 (de) 2010-11-11
JP4125672B2 (ja) 2008-07-30
JP2004535444A (ja) 2004-11-25
BR0210701A (pt) 2004-07-20
WO2003002498A1 (en) 2003-01-09
AU2002321068B2 (en) 2007-11-15
KR100898887B1 (ko) 2009-05-21
US20040176432A1 (en) 2004-09-09
CN1520390A (zh) 2004-08-11
EP1399402B1 (en) 2010-09-29
CA2449800C (en) 2009-09-29
ES2349918T3 (es) 2011-01-13
CY1111510T1 (el) 2015-08-05
MXPA03010914A (es) 2004-02-17
CA2449800A1 (en) 2003-01-09
ZA200309101B (en) 2005-03-30

Similar Documents

Publication Publication Date Title
DE60131676D1 (de) Verfahren zur herstellung einer maus, die für die aufnahme, differenzierung und proliferation von heterogenen zellen geeignet ist, die hierdurch hergestellte maus und ihre verwendung
GR3026496T3 (en) Tetrazole derivatives of bile acids, a process for their production and their use as medicines.
MX9706080A (es) 1,3-cetoenoles heterociclicos 2-fenil-sustituidos como herbicidas pesticidas.
CY1111510T1 (el) Ενδιαμεσα παραγωγα αλογονοφaiνυλiου και η χρηση αυτων σε μια μεθοδο για την παρασκευη παραγωγων αζολης
HUT70445A (en) Aryl-substituted heterocycles, process for producing thereof and pharmaceutical compositions comprising them
DE502005002356D1 (de) Neue 2-benzylaminodihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE487746T1 (de) Geträgerter hybridmetallocenkatalysator, herstellungsverfahren dafür und verfahren zur herstellung von polyolefinen damit
NO20033141L (no) Fremgangsmåte for behandling av et metallfyllstoff med et polydialkylsiloksan og en fettsyre, de resulterende hydrofobe fyllstoffer samtderes anvendelse ipolymerer for pustende filmer
BR0214845A (pt) Sìntese de 4,5-diidro-pirazol[3,4-c]pirid-2-onas
ATE356797T1 (de) Azidfreies verfahren zur herstellung von 1,2- diaminoverbindungen
ATE370150T1 (de) Verfahren zur herstellung von salzen schwach koordinierender aniomen, derartige salze sowie deren verwendung
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
EP1136063A3 (de) Abrasivum auf Basis von biologischem Material und Verfahren zu dessen Herstellung
ATE553095T1 (de) Neue imidazolderivate, deren herstellung und deren verwendung als intermediate zur herstellung von arzneimitteln und pestiziden
WO2004108664A3 (de) Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
ATE237585T1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
ATE442459T1 (de) MIKROORGANISMUS MIT EINEM ßKNOCK-OUTß FADR GEN UND DESSEN VERWENDUNG IN EINEM VERFAHREN ZUR HERSTELLUNG VON L-THREONIN
DE69418581D1 (de) Verfahren zur herstellung dünner bleche, geeignet für die anfertigung von dosenteilen
ATE296786T1 (de) Verbund-sicherheitsglas und verfahren zu dessen herstellung
ATE270665T1 (de) Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE69523794D1 (de) Kornwachstumsverfahren für die Herstellung von Hochbromidemulsionen mit ultradünnen tafelförmigen Körnern
DE50110561D1 (de) Non-metallocene, verfahren zur herstellung von diesen und deren verwendung zur polymerisation von olefinen
DE60112241D1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
WO2000017176A3 (de) Benzolylguanidin-abkömmlinge mit vorteilhaften eigenschaften, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von arzneimiteln
Chang et al. A synthesis of thalidomide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1399402

Country of ref document: EP